Founded: 2017
Invested: 2017
Location: Montreal, Quebec
Industry: Life Sciences

Company Overview: Nanogenecs is building a convenient and inexpensive medical diagnostic portable platform that measures your blood chemistry in a matter of minutes to deliver actionable insights. Such insights will improve the management of chronic diseases, bringing the safeguard high-quality laboratory testing at home.

Our Story: Ripple met the founder and CEO of Nanogenecs, Shahid Azim in Sept 2017 in Boston and was immediately attracted to the high quality team surrounding this venture. With high profile industry executives helping take the Nanogenecs technology from lab to market, Ripple decided to lead the angel investment round in the company.

Ripple Ventures is a genuine early stage investor that brings a strong desire to help founders build high impact ventures. Their open and supportive approach has helped us tremendously to focus on things that matter most. As a serial entrepreneur, I would strongly recommend them to anyone looking for smart capital.
— Shahid Azim, CEO & Co-Founder, Nanogenecs